Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Wikipedia's Most Viewed Stories 2023
Wikipedia has released its list of most viewed articles for 2023 with the site seeing over 84 billion visits. The most searched topic was ChatGPT with nearly 50 billion page views
Closing Arguments in Jetblue-Spirit Airlines Merger Case
Closing arguments are happening in a federal trial over whether Jetblue Airways will be allowed to buy Spirit Airlines for $3.8 billion.
Report: J&J Looking to Settle Baby Powder Lawsuits
Johnson and Johnson is reportedly looking to settle multiple lawsuits claiming that its baby powder causes cancer, according to Bloomberg.
Wells Fargo CEO: Q4 Severance Costs May Be Near $1 Billion
Wells Fargo said it could face nearly $1 billion in severance costs in the fourth quarter.
Supreme Court Throws Out Case That Could Have Limited Lawsuits Over Disability Access
The Supreme Court on Tuesday dismissed a case surrounding a Maine hotel that could have made it harder for people with disabilities to learn in advance whether a hotel's accommodations meet their needs.
'GTA VI' Trailer Releases Early After Leak
The highly-anticipated trailer for Grand Theft Auto VI is out earlier than expected.
AT&T Selects Ericsson to Build New Network
AT&T announced a new partnership with Swedish communications company Ericsson.
23andMe Data Hack Affects 6.9 Million Users
Hackers accessed the personal data of 6.9 million users via the genetic testing company 23andMe.
Stocks Fall After Losing Session on Monday
Stocks fell after the opening bell on Tuesday morning as signs pointed to another losing session.
